const REACTION_TYPES = ['like', 'love', 'laugh', 'wow', 'celebrate', 'think'];

const MOCK_USERS = [
  { id: 101, name: 'Sarah Chen', username: 'sarah_chen', avatar_url: 'https://i.pravatar.cc/150?img=1' },
  { id: 102, name: 'Marcus Johnson', username: 'marcus_j', avatar_url: 'https://i.pravatar.cc/150?img=2' },
  { id: 103, name: 'Emily Rodriguez', username: 'emily_r', avatar_url: 'https://i.pravatar.cc/150?img=3' },
  { id: 104, name: 'David Park', username: 'david_park', avatar_url: 'https://i.pravatar.cc/150?img=4' },
  { id: 105, name: 'Lisa Wang', username: 'lisa_wang', avatar_url: 'https://i.pravatar.cc/150?img=5' },
  { id: 106, name: 'James Kim', username: 'james_kim', avatar_url: 'https://i.pravatar.cc/150?img=6' }
];

const getCrypto = () => {
  if (typeof window !== 'undefined' && window.crypto && window.crypto.getRandomValues) {
    return window.crypto;
  }

  return null;
};

const createRandomId = (cryptoImpl) =>
  Array.from(cryptoImpl.getRandomValues(new Uint8Array(16)))
    .map((value) => value.toString(16).padStart(2, '0'))
    .join('');

const createFallbackId = () =>
  Array.from({ length: 32 })
    .map(() => Math.floor(Math.random() * 16).toString(16))
    .join('');

const createTokenSafeId = () => {
  const cryptoImpl = getCrypto();
  if (cryptoImpl) {
    return createRandomId(cryptoImpl);
  }
  return createFallbackId();
};

const generateMockReactions = (count, includeCurrentUser = false, currentUserType = null) => {
  const reactions = [];

  if (includeCurrentUser && currentUserType) {
    reactions.push({
      id: createTokenSafeId(),
      type: currentUserType,
      user: { id: 'current-user', name: 'You', username: 'you', avatar_url: '' }
    });
  }

  for (let i = 0; i < count - (includeCurrentUser ? 1 : 0); i += 1) {
    reactions.push({
      id: createTokenSafeId(),
      type: REACTION_TYPES[Math.floor(Math.random() * REACTION_TYPES.length)],
      user: MOCK_USERS[i % MOCK_USERS.length]
    });
  }

  return reactions;
};

const createBasePosts = () => [
  {
    id: 1,
    author: {
      id: 1,
      name: 'Dr. Alice Johnson',
      username: 'alice_researcher',
      avatar: 'https://i.pravatar.cc/150?img=1',
      credentials: 'PhD, Neuroscience',
      verified: true,
      reputation: 95
    },
    content:
      'Excited to share our latest findings on psilocybin and neuroplasticity! The results from our 6-month study show remarkable improvements in neural connectivity. Full paper coming soon. ðŸ§ âœ¨',
    images: [],
    offsetMs: 2 * 60 * 60 * 1000,
    reactions: generateMockReactions(156, false),
    currentUserReaction: null,
    comments: 23,
    shares: 12,
    saves: 45,
    views: 1240,
    isBookmarked: false,
    tags: ['research', 'psilocybin', 'neuroscience'],
    contentType: 'post'
  },
  {
    id: 2,
    author: {
      id: 9,
      name: 'Dr. Priya Sharma',
      username: 'priya_psychiatrist',
      avatar: 'https://i.pravatar.cc/150?img=20',
      credentials: 'MD, Psychiatry',
      verified: true,
      reputation: 88
    },
    content:
      'Just wrapped up an incredible session with a patient showing complete remission from depression after psilocybin therapy. These moments remind me why this work matters. ðŸ’œ',
    images: ['https://images.unsplash.com/photo-1576091160399-112ba8d25d1d?w=800&h=600&fit=crop'],
    offsetMs: 3 * 60 * 60 * 1000,
    reactions: generateMockReactions(289, false),
    currentUserReaction: null,
    comments: 48,
    shares: 34,
    saves: 78,
    views: 2100,
    isBookmarked: true,
    tags: ['clinical', 'psilocybin', 'success'],
    contentType: 'post'
  },
  {
    id: 3,
    author: {
      id: 2,
      name: 'Prof. Robert Williams',
      username: 'bob_neuroscience',
      avatar: 'https://i.pravatar.cc/150?img=12',
      credentials: 'Professor, MIT',
      reputation: 92
    },
    content:
      'Anyone attending the Psychedelic Science Symposium next month? Would love to connect and discuss collaboration opportunities!',
    images: [],
    offsetMs: 5 * 60 * 60 * 1000,
    reactions: generateMockReactions(89, true, 'celebrate'),
    currentUserReaction: 'celebrate',
    comments: 34,
    shares: 5,
    saves: 12,
    views: 650,
    isBookmarked: false,
    tags: ['conference', 'networking'],
    contentType: 'event'
  },
  {
    id: 4,
    author: {
      id: 17,
      name: 'Dr. Jessica Turner',
      username: 'jessica_clinical',
      avatar: 'https://i.pravatar.cc/150?img=47',
      credentials: 'PsyD',
      verified: true,
      reputation: 85
    },
    content:
      'ðŸŽ‰ Just completed the MAPS MDMA Therapy Training Program! Feeling grateful to join this incredible community of therapists. Looking forward to bringing this work to more people who need it.',
    images: ['https://images.unsplash.com/photo-1587825140708-dfaf72ae4b04?w=800&h=600&fit=crop'],
    offsetMs: 8 * 60 * 60 * 1000,
    reactions: generateMockReactions(412, false),
    currentUserReaction: null,
    comments: 76,
    shares: 89,
    saves: 124,
    views: 3200,
    isBookmarked: false,
    tags: ['training', 'mdma', 'maps', 'milestone'],
    contentType: 'post'
  },
  {
    id: 5,
    author: {
      id: 12,
      name: 'Dr. Miguel Alvarez',
      username: 'miguel_neuro',
      avatar: 'https://i.pravatar.cc/150?img=33',
      credentials: 'PhD, Neuropharmacology',
      reputation: 90
    },
    content:
      'Our lab just published a new paper on the role of serotonin receptors in psychedelic experiences. Sharing the preprint link for anyone interested in the molecular mechanisms!',
    images: [],
    offsetMs: 24 * 60 * 60 * 1000,
    reactions: generateMockReactions(134, false),
    currentUserReaction: null,
    comments: 19,
    shares: 27,
    saves: 56,
    views: 980,
    isBookmarked: true,
    tags: ['research', 'serotonin', 'paper'],
    contentType: 'paper'
  },
  {
    id: 6,
    author: {
      id: 21,
      name: 'GSAPS Community',
      username: 'gsaps_official',
      avatar: 'https://i.pravatar.cc/150?img=9',
      credentials: 'Official Account',
      verified: true,
      reputation: 100
    },
    content:
      "ðŸ“¢ Reminder: Applications for the 2024 Clinical Research Fellowship close this Friday! Don't miss the chance to work with leading psychedelic researchers across the globe.",
    images: [],
    offsetMs: 26 * 60 * 60 * 1000,
    reactions: generateMockReactions(245, false),
    currentUserReaction: null,
    comments: 54,
    shares: 71,
    saves: 89,
    views: 1850,
    isBookmarked: false,
    tags: ['announcement', 'fellowship', 'opportunity'],
    contentType: 'post'
  },
  {
    id: 7,
    author: {
      id: 8,
      name: 'Dr. Amina Hassan',
      username: 'amina_psych',
      avatar: 'https://i.pravatar.cc/150?img=31',
      credentials: 'MD, Psychotherapy',
      reputation: 87
    },
    content:
      'Sharing a case study on integrating psilocybin therapy with cognitive behavioral approaches. The combined outcomes are fascinating and promising for treatment-resistant cases.',
    images: ['https://images.unsplash.com/photo-1527236438218-d82077ae1f85?w=800&h=600&fit=crop'],
    offsetMs: 32 * 60 * 60 * 1000,
    reactions: generateMockReactions(178, false),
    currentUserReaction: null,
    comments: 41,
    shares: 22,
    saves: 67,
    views: 1320,
    isBookmarked: false,
    tags: ['case-study', 'therapy', 'integration'],
    contentType: 'post'
  },
  {
    id: 8,
    author: {
      id: 14,
      name: 'Dr. Omar Singh',
      username: 'omar_research',
      avatar: 'https://i.pravatar.cc/150?img=18',
      credentials: 'PhD, Pharmacology',
      reputation: 82
    },
    content:
      'New funding opportunity alert! The Psychedelic Research Fund just announced grants for community-based research projects. Sharing the application details inside.',
    images: [],
    offsetMs: 40 * 60 * 60 * 1000,
    reactions: generateMockReactions(92, false),
    currentUserReaction: null,
    comments: 11,
    shares: 18,
    saves: 34,
    views: 780,
    isBookmarked: false,
    tags: ['funding', 'community', 'grant'],
    contentType: 'post'
  },
  {
    id: 9,
    author: {
      id: 15,
      name: 'Dr. Emma Laurent',
      username: 'emma_psychedelics',
      avatar: 'https://i.pravatar.cc/150?img=24',
      credentials: 'PhD, Clinical Psychology',
      reputation: 91
    },
    content:
      "Hosting a webinar next week on ethical considerations in psychedelic therapy practice. Drop your questions belowâ€”we'll address them live!",
    images: ['https://images.unsplash.com/photo-1542314831-068cd1dbfeeb?w=800&h=600&fit=crop'],
    offsetMs: 48 * 60 * 60 * 1000,
    reactions: generateMockReactions(310, false),
    currentUserReaction: null,
    comments: 112,
    shares: 64,
    saves: 156,
    views: 2850,
    isBookmarked: true,
    tags: ['webinar', 'ethics', 'therapy'],
    contentType: 'event'
  },
  {
    id: 10,
    author: {
      id: 4,
      name: 'Research Lab Alpha',
      username: 'lab_alpha',
      avatar: 'https://i.pravatar.cc/150?img=15',
      credentials: 'Academic Lab',
      reputation: 78
    },
    content:
      "We're hiring! Looking for a post-doc with experience in psychedelic pharmacology and neuroimaging. Remote collaboration possible. DM for details or apply via our careers page.",
    images: [],
    offsetMs: 72 * 60 * 60 * 1000,
    reactions: generateMockReactions(67, false),
    currentUserReaction: null,
    comments: 15,
    shares: 9,
    saves: 23,
    views: 520,
    isBookmarked: false,
    tags: ['hiring', 'research', 'careers'],
    contentType: 'post'
  },
  {
    id: 11,
    author: {
      id: 25,
      name: 'Dr. Kenji Tanaka',
      username: 'kenji_neuroimaging',
      avatar: 'https://i.pravatar.cc/150?img=25',
      credentials: 'PhD, Neuroimaging',
      verified: true,
      reputation: 93
    },
    content:
      'Breakthrough in fMRI research! Our team identified specific neural signatures during DMT experiences that correlate with ego dissolution. This could revolutionize how we understand consciousness. Paper link in comments.',
    images: ['https://images.unsplash.com/photo-1559757148-5c350d0d3c56?w=800&h=600&fit=crop'],
    offsetMs: 1 * 60 * 60 * 1000,
    reactions: generateMockReactions(523, false),
    currentUserReaction: null,
    comments: 134,
    shares: 156,
    saves: 234,
    views: 5600,
    isBookmarked: false,
    tags: ['research', 'dmt', 'neuroscience', 'consciousness'],
    contentType: 'paper'
  },
  {
    id: 12,
    author: {
      id: 28,
      name: 'Dr. Sofia Martinez',
      username: 'sofia_indigenous',
      avatar: 'https://i.pravatar.cc/150?img=28',
      credentials: 'Anthropologist',
      verified: true,
      reputation: 89
    },
    content:
      'Important discussion on reciprocity and respect in psychedelic research. We must honor indigenous knowledge keepers who have safeguarded these medicines for millennia. Thread on ethical engagement with traditional communities ðŸ§µ',
    images: [],
    offsetMs: 4 * 60 * 60 * 1000,
    reactions: generateMockReactions(267, false),
    currentUserReaction: null,
    comments: 89,
    shares: 112,
    saves: 98,
    views: 2340,
    isBookmarked: false,
    tags: ['ethics', 'indigenous', 'reciprocity', 'culture'],
    contentType: 'post'
  },
  {
    id: 13,
    author: {
      id: 30,
      name: 'Clinical Trials Network',
      username: 'ctn_psychedelics',
      avatar: 'https://i.pravatar.cc/150?img=30',
      credentials: 'Research Organization',
      verified: true,
      reputation: 96
    },
    content:
      'ðŸ“Š Phase 3 trial results just released: Psilocybin shows 67% response rate for treatment-resistant depression vs 32% placebo. Effect sustained at 12-month follow-up. This is the data we\'ve been waiting for!',
    images: ['https://images.unsplash.com/photo-1532094349884-543bc11b234d?w=800&h=600&fit=crop'],
    offsetMs: 6 * 60 * 60 * 1000,
    reactions: generateMockReactions(789, false),
    currentUserReaction: null,
    comments: 201,
    shares: 298,
    saves: 412,
    views: 8900,
    isBookmarked: true,
    tags: ['research', 'clinical-trial', 'psilocybin', 'depression'],
    contentType: 'paper'
  },
  {
    id: 14,
    author: {
      id: 32,
      name: 'Dr. Layla Osman',
      username: 'layla_integration',
      avatar: 'https://i.pravatar.cc/150?img=32',
      credentials: 'Integration Therapist',
      reputation: 84
    },
    content:
      'The journey doesn\'t end when the session does. Integration is where the real transformation happens. Sharing my top 5 integration practices that help clients embody their insights and create lasting change.',
    images: [],
    offsetMs: 12 * 60 * 60 * 1000,
    reactions: generateMockReactions(198, false),
    currentUserReaction: null,
    comments: 56,
    shares: 67,
    saves: 145,
    views: 1560,
    isBookmarked: false,
    tags: ['integration', 'therapy', 'practice'],
    contentType: 'post'
  },
  {
    id: 15,
    author: {
      id: 35,
      name: 'Prof. Dimitri Volkov',
      username: 'dimitri_philosophy',
      avatar: 'https://i.pravatar.cc/150?img=35',
      credentials: 'Professor, Philosophy of Mind',
      verified: true,
      reputation: 91
    },
    content:
      'New course launching next month: "Consciousness, Psychedelics, and the Hard Problem" - exploring philosophical implications of psychedelic phenomenology. Open to researchers and practitioners. Early bird discount ends Friday!',
    images: ['https://images.unsplash.com/photo-1516321497487-e288fb19713f?w=800&h=600&fit=crop'],
    offsetMs: 18 * 60 * 60 * 1000,
    reactions: generateMockReactions(156, false),
    currentUserReaction: null,
    comments: 43,
    shares: 52,
    saves: 89,
    views: 1240,
    isBookmarked: false,
    tags: ['course', 'philosophy', 'consciousness', 'education'],
    contentType: 'course'
  },
  {
    id: 16,
    author: {
      id: 38,
      name: 'Dr. Aisha Patel',
      username: 'aisha_safety',
      avatar: 'https://i.pravatar.cc/150?img=38',
      credentials: 'MD, Risk Management',
      verified: true,
      reputation: 94
    },
    content:
      'âš ï¸ Critical safety update: New contraindication guidelines for psychedelic therapy with certain SSRIs. Please review if you\'re a practitioner. Patient safety must always come first. Full medical advisory attached.',
    images: [],
    offsetMs: 20 * 60 * 60 * 1000,
    reactions: generateMockReactions(334, false),
    currentUserReaction: null,
    comments: 78,
    shares: 189,
    saves: 267,
    views: 3450,
    isBookmarked: true,
    tags: ['safety', 'clinical', 'guidelines', 'medical'],
    contentType: 'post'
  },
  {
    id: 17,
    author: {
      id: 40,
      name: 'Mycology Society',
      username: 'mushroom_science',
      avatar: 'https://i.pravatar.cc/150?img=40',
      credentials: 'Research Community',
      verified: true,
      reputation: 86
    },
    content:
      'ðŸ„ Fascinating microscopy images showing psilocybin crystal formation in cubensis fruiting bodies. The beauty of nature and chemistry combined! High-resolution images available for research purposes.',
    images: ['https://images.unsplash.com/photo-1506976785307-8732e854ad03?w=800&h=600&fit=crop'],
    offsetMs: 28 * 60 * 60 * 1000,
    reactions: generateMockReactions(445, false),
    currentUserReaction: null,
    comments: 92,
    shares: 78,
    saves: 156,
    views: 4200,
    isBookmarked: false,
    tags: ['mycology', 'science', 'psilocybin', 'research'],
    contentType: 'post'
  },
  {
    id: 18,
    author: {
      id: 42,
      name: 'Dr. Marcus Chen',
      username: 'marcus_ptsd',
      avatar: 'https://i.pravatar.cc/150?img=42',
      credentials: 'PTSD Specialist',
      verified: true,
      reputation: 88
    },
    content:
      'Veteran PTSD treatment results are incredibly promising. Seeing combat veterans find peace after decades of suffering. MDMA-assisted therapy is providing hope where conventional treatments fell short. We need FDA approval now.',
    images: [],
    offsetMs: 36 * 60 * 60 * 1000,
    reactions: generateMockReactions(512, false),
    currentUserReaction: null,
    comments: 145,
    shares: 201,
    saves: 178,
    views: 5100,
    isBookmarked: false,
    tags: ['ptsd', 'mdma', 'veterans', 'clinical'],
    contentType: 'post'
  },
  {
    id: 19,
    author: {
      id: 45,
      name: 'Dr. Yuki Nakamura',
      username: 'yuki_music',
      avatar: 'https://i.pravatar.cc/150?img=45',
      credentials: 'Music Therapist',
      reputation: 82
    },
    content:
      'ðŸŽµ New research on music selection in psychedelic therapy. We analyzed 200+ sessions and found specific musical elements that enhance therapeutic outcomes. Sharing our curated playlist protocol - journal article in comments.',
    images: ['https://images.unsplash.com/photo-1511379938547-c1f69419868d?w=800&h=600&fit=crop'],
    offsetMs: 44 * 60 * 60 * 1000,
    reactions: generateMockReactions(223, false),
    currentUserReaction: null,
    comments: 67,
    shares: 89,
    saves: 234,
    views: 2100,
    isBookmarked: false,
    tags: ['music', 'therapy', 'research', 'protocol'],
    contentType: 'paper'
  },
  {
    id: 20,
    author: {
      id: 48,
      name: 'Policy Reform Alliance',
      username: 'pra_advocacy',
      avatar: 'https://i.pravatar.cc/150?img=48',
      credentials: 'Advocacy Group',
      verified: true,
      reputation: 87
    },
    content:
      'ðŸ—³ï¸ Oregon\'s Measure 109 implementation update: First licensed service centers opening next month! This is history in the making. Sign up for our webinar on navigating the new legal landscape for practitioners.',
    images: [],
    offsetMs: 50 * 60 * 60 * 1000,
    reactions: generateMockReactions(389, false),
    currentUserReaction: null,
    comments: 156,
    shares: 234,
    saves: 198,
    views: 4560,
    isBookmarked: false,
    tags: ['policy', 'oregon', 'legalization', 'advocacy'],
    contentType: 'event'
  },
  {
    id: 21,
    author: {
      id: 50,
      name: 'Dr. Elena Rossi',
      username: 'elena_neuropharm',
      avatar: 'https://i.pravatar.cc/150?img=50',
      credentials: 'PhD, Neuropharmacology',
      verified: true,
      reputation: 90
    },
    content:
      'Comparative pharmacokinetics of different psilocybin formulations. Our lab tested absorption rates, bioavailability, and subjective effects. Surprising findings on optimal dosing strategies. Pre-print available now!',
    images: [],
    offsetMs: 60 * 60 * 60 * 1000,
    reactions: generateMockReactions(167, false),
    currentUserReaction: null,
    comments: 45,
    shares: 56,
    saves: 112,
    views: 1340,
    isBookmarked: false,
    tags: ['pharmacology', 'psilocybin', 'research', 'dosing'],
    contentType: 'paper'
  }
];

const withTimestamps = (posts) => {
  const now = Date.now();
  return posts.map(({ offsetMs, ...post }) => ({
    ...post,
    timestamp: new Date(now - offsetMs)
  }));
};

const delay = (ms = 400) => new Promise((resolve) => setTimeout(resolve, ms));

export const generateMockFeedPosts = () => withTimestamps(createBasePosts());

export const fetchMockPosts = async (filter = 'all') => {
  await delay();
  const posts = generateMockFeedPosts();

  if (filter === 'trending') {
    return [...posts].sort(
      (a, b) => b.reactions.length + b.comments + b.shares - (a.reactions.length + a.comments + a.shares)
    );
  }

  if (filter === 'following') {
    const followedUsernames = new Set(['alice_researcher', 'priya_psychiatrist', 'gsaps_official']);
    return posts.filter((post) => followedUsernames.has(post.author.username));
  }

  return posts;
};

export default fetchMockPosts;
